Germany’s Federal Cartel Office has reportedly cleared medical equipment maker B. Braun to increase its stake in hospital operator Rhoen-Klinikum to 25 percent, according to reports.
B. Braun requested regulatory clearance for the deal last month as part of an effort to prevent the hospital operator’s takeover by rival Fresenius. Despite the efforts, since a deal with B. Braun was struck, reports say Rhoen and Fresenius have struck their own deal that sees Fresenius acquire most of Rhoen hospitals.
As such, reports are now questioning whether B. Braun will continue with the deal to increase its stake in Rhoen; a company spokesperson declined to comment on that matter.
B. Braun acquired a 5 percent share of Rhoen last year.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI